Page results
-
We are expanding the type of results that will be shared with patients through our patient portal MyCare UCLH.
-
Information about activating your MyCare UCLH app.
-
Information about the Integrated General Medicine Service at the RLHIM patient information leaflet.
-
Information supporting adults affected by cancer and blood conditions being treated at UCLH.
-
Information for patients having chemotherapy for ovarian, tubal or primary peritoneal cancer, or who have been newly diagnosed with pancreatic cancer or cholangiocarcinoma.
-
This page has been written by the Neuropsychiatry Department at the National Hospital for Neurology and Neurosurgery. The aim of this page is to provide general information about the procedure called Repetitive Transcranial Magnetic Stimulation (rTMS).
-
This information has been written for patients who have been referred for High Dose Rate (HDR) brachytherapy to the oesophagus (gullet).
-
This page has been written for patients who have been referred for High Dose Rate (HDR) brachytherapy to the bronchus
-
This page provides an overview of our Teenage and Young Adult (TYA) Ambulatory Care Service available to patients aged 12 to 24 years.
-
This page provides information about post procedural care following a diagnostic angiogram or endovascular treatment and possible complications that may occur.
File results
-
FOI/2024/0478 - Elective operations cancelled for non-clinical reasons 2021/22-2023/24
-
FOI/2024/0473 - Elective operations cancelled for non-clinical reasons 2023/24
-
FOI/2024/0354 - Staff details for estates and facilities
-
FOI/2024/0349 - Trust's operations and tele reporting services/ outsourced and insourced
-
FOI/2024/0347 - Paediatric elective surgical waiting lists
-
FOI/2024/0326 - Treatment of Haemophilia B and Von Willebrand disease
-
FOI/2024/0464 - Theatre sessions/ productivity
-
FOI/2024/0329 - Metastatic renal cell carcinoma patients/ classification
-
FOI/2024/0327 - Treatment of non-UK nationals
-
FOI/2024/0467 - Drug Patient Level Contract Monitoring (DrPLCM) and SACT Cancer reports